Thus, the molecular mechanisms will be further studied and in vivo experiments will be performed to reveal the anti-metastatic properties of α-linolenic acid in tumor growth and metastasis, and determine whether FASN is a promising target and prognostic predictor for treating osteosarcoma. This evidence concerns the gene FASN and osteosarcoma.